Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Development of novel vaccine therapy, based on intracellular direct antigen release nanocarriers
| Reference number | 2007-00216 |
| Coordinator | Lunds universitet - Institutionen för immunteknologi |
| Funding from Vinnova | SEK 1 400 000 |
| Project duration | September 2007 - August 2009 |
| Status | Completed |
